Suggestions appear as you type. Use the up and down arrows to choose one and Enter to open it.

This page's audience our own tag's counts — open to see them
–Visits
–Page views
–Clicks to vendors
–Time on page
–Reading now
Clicks to vendors, by tool
  • –
Top countries
  • –
Devices
  • –

– · visits, page views and clicks counted by our own tag, which counts more than our checked analytics; every figure rounded down · how we count

Head-to-head · AI Drug Discovery Software

Pharma.AI vs Iktos

  • Updated Oct 2026
  • Both researched from official sources
  • 4 checks side by side
Higher score Pharma.AI #2 in AI Drug Discovery Software 8.8/10 Pricing on request ✓ 4 of 4 features Contact Insilico
Iktos #5 in AI Drug Discovery Software 7.9/10 Pricing on request ✓ 3 of 4 features Visit Iktos

Pharma.AI leads on 0 checks, Iktos on 0, and 4 are even. Who comes out ahead on the 4 yes/no, price and count checks where we have data for both products. The editor score weighs everything else too.

Our verdict

  • Highest scorePharma.AI · 8.8/10
  • Most featuresPharma.AI · 4 of 4

Pharma.AI scores higher on our rubric for ai drug discovery software: 8.8 against 7.9 out of 10; our editors rank them #2 and #5.

Pharma.AI is the better fit for teams seeking a broad discovery and research suite. Iktos is the better fit for teams combining molecular design with automated testing.

  • Pharma.AI fits best

    Teams seeking a broad discovery and research suite

  • Iktos fits best

    Teams combining molecular design with automated testing

Advertiser disclosure: iTechGuides is reader-supported. Vendors can pay for top positions in our rankings and for a place on other products' pages, and we may earn a commission when you click some links. Bought places stand at the number bought; this page and our disclosure say so. Paying vendors may get a fuller, more detailed review from our editors, and that review can change their score. How we rank.

Side by side

Feature Pharma.AI 8.8/10 Visit ↗ Iktos 7.9/10 Visit ↗
At a glance
Editor score 8.8 7.9
Ranking #2 in AI Drug Discovery Software #5 in AI Drug Discovery Software
Best for Teams seeking a broad discovery and research suite Teams combining molecular design with automated testing
Pricing model Paid Paid
Starting price Pricing on request Pricing on request
Free plan Not checked yet Not checked yet
Free trial — —
Deployment Cloud Cloud
Platforms Web Web
Support Email Email
Built for Mid-market, Enterprise Mid-market, Enterprise
Features Pharma.AI 4/4 · Iktos 3/4
Target identification ✓ ✓
Molecule design ✓ ✓
Drug repurposing ✓ (best) Not checked yet
Research publications ✓ ✓
Specs
Discovery scope Suite Suite
Deployment options Not checked yet Both
Our review
Pros
  • Analyzes multi-omics and text evidence for target prioritization
  • Supports small-molecule and biologics design and optimization
  • Includes repositioning, clinical-trial prediction and research workflows
  • Generates molecules against target product profile constraints
  • Combines SAR, ADMET, and multi-parameter compound scoring
  • Connects design with automated synthesis and biological testing workflows
Cons
  • Pricing requires contacting Insilico Medicine
  • Access is cloud-based, with web listed as the platform
  • Broad scope may not suit teams seeking a focused single-stage tool
  • Pricing is available through contact sales
  • The listed support channel is email
  • The platform's components and workflows may call for specialist drug-discovery teams
Our verdict

Pharma.AI is Insilico Medicine’s commercial software suite for pharmaceutical research and development. It is aimed at mid-market and enterprise R&D teams that want computational support across multiple stages of discovery. PandaOmics…

Read the review →

Iktos brings molecule design, retrosynthesis, and laboratory automation into a drug-discovery suite for pharmaceutical, biotech, and academic teams. Makya supports ligand- and structure-based molecular modeling, with target product profile…

Read the review →
  1. Pharma.AIAI Drug Discovery Software 8.8Pricing on request
  2. IktosAI Drug Discovery Software 7.9Pricing on request

Strengths and trade-offs

  • Pharma.AI — where it wins

    • Analyzes multi-omics and text evidence for target prioritization
    • Supports small-molecule and biologics design and optimization
    • Includes repositioning, clinical-trial prediction and research workflows

    Where it doesn't

    • Pricing requires contacting Insilico Medicine
    • Access is cloud-based, with web listed as the platform
    • Broad scope may not suit teams seeking a focused single-stage tool

  • Iktos — where it wins

    • Generates molecules against target product profile constraints
    • Combines SAR, ADMET, and multi-parameter compound scoring
    • Connects design with automated synthesis and biological testing workflows

    Where it doesn't

    • Pricing is available through contact sales
    • The listed support channel is email
    • The platform's components and workflows may call for specialist drug-discovery teams
  • Pharma.AI8.8/10 · Pricing on request

    A broad discovery suite spanning target research, molecule design and clinical-trial prediction.

    Contact InsilicoFull verdict →
  • Iktos7.9/10 · Pricing on request

    A drug-discovery suite linking constrained molecule design to automated synthesis and testing.

    Visit IktosFull verdict →

More comparisons

All AI drug discovery software comparisons → · Full ranking →

Guides on AI drug discovery software

Reviewed by iTechGuides Editors · Editorial team · Updated Oct 2026

Last updated · How we research and update